Followers | 0 |
Posts | 885 |
Boards Moderated | 0 |
Alias Born | 02/15/2016 |
Saturday, March 03, 2018 3:24:12 PM
we may have a bit to go to find a bottom
this company has a ways to go to be legit
thr pharmacuetical plays though have potential for billion dollar valuations because
of the high barriers to entry
i think we may see some 5-6 cents for a bottom
australian side has some support at .088 aus but
another lackluster quarter could see that blown out
just realized they only own 51% of the derma division
not excited about that it will limit the explosion there
thanks to the hc folks explaning cannepil can
be sold unregisterd in australia but until they get through
the rest of the trials sounds like cannepil is a no go in europe
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM